HKSE - Delayed Quote HKD
Beijing Biostar Pharms Co Ltd (2563.HK)
4.410
-0.930
(-17.42%)
As of March 31 at 4:08:28 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-131,293
-149,332
-79,438
Investing Cash Flow
40,763
129,829
-146,788
Financing Cash Flow
-974
-1,130
3,533
End Cash Position
34,286
38,087
60,106
Capital Expenditure
-46,865
-27,840
-32,678
Free Cash Flow
-178,158
-177,172
-112,116
12/31/2022 - 10/31/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
303.400
+1.61%
1952.HK Everest Medicines Limited
46.300
-6.84%
1530.HK 3SBIO
13.340
+4.22%
1548.HK GENSCRIPT BIO
11.060
+0.18%
9688.HK Zai Lab Limited
25.700
-1.15%
1177.HK SINO BIOPHARM
3.860
+0.52%
9926.HK Akeso, Inc.
99.000
+6.57%
1801.HK INNOVENT BIO
54.050
+5.05%
2269.HK WuXi Biologics (Cayman) Inc.
22.700
0.00%